In general, three different therapeutical approaches based on subretinal injection have been established in retinal research: while the injection of tissue plasminogen activator (tPA) close to AMD-associated submacular hemorrhages has already found its way into clinical practice [4, 5], subretinal gene therapy and stem cell injections are the subjects of current animal experimental and clinical studies. Here, PLAT is linked to age-related macular degeneration.